Table 3.
Parameters |
Intra-group
correlation coefficient (ICC) |
P-value | 95% credibility interval |
---|---|---|---|
T 2 WI degenerative hysteromyoma group ( n = 24) | |||
Mean | 0.990 | P < 0.001 | 0.978–0.996 |
Variance | 0.972 | P < 0.001 | 0.936–0.998 |
Skewness | 0.837 | P < 0.001 | 0.66–0.926 |
Kurtosis | 0.905 | P < 0.001 | 0.794–0.958 |
1th percentile | 0.949 | P < 0.001 | 0.885–0.977 |
10th percentile | 0.982 | P < 0.001 | 0.960–0.992 |
50th percentile | 0.992 | P < 0.001 | 0.983–0.997 |
90th percentile | 0.989 | P < 0.001 | 0.975–0.995 |
99th percentile | 0.986 | P < 0.001 | 0.967–0.994 |
ADC degenerative hysteromyoma group ( n = 24) | |||
Mean | 0.981 | P < 0.001 | 0.955–0.922 |
Variance | 0.908 | P < 0.001 | 0.788–0.962 |
Skewness | 0.924 | P < 0.001 | 0.822–0.968 |
Kurtosis | 0.924 | P < 0.001 | 0.822–0.968 |
1thpercentile | 0.941 | P < 0.001 | 0.862–0.976 |
10th percentile | 0.975 | P < 0.001 | 0.939–0.990 |
50th percentile | 0.978 | P < 0.001 | 0.946–0.991 |
90th percentile | 0.986 | P < 0.001 | 0.965–0.994 |
99th percentile | 0.894 | P < 0.001 | 0.757–0.955 |
T 1 CE degenerative hysteromyoma group ( n = 24) | |||
Mean | 0.996 | P < 0.001 | 0.989–0.998 |
Variance | 0.990 | P < 0.001 | 0.974–0.996 |
Skewness | 0.941 | P < 0.001 | 0.853–0.977 |
Kurtosis | 0.911 | P < 0.001 | 0.784–0.965 |
1th percentile | 0.981 | P < 0.001 | 0.952–0.993 |
10th percentile | 0.992 | P < 0.001 | 0.981–0.997 |
50th percentile | 0.995 | P < 0.001 | 0.897–0.998 |
90th percentile | 0.995 | P < 0.001 | 0.987–0.998 |
99th percentile | 0.990 | P < 0.001 | 0.974–0.996 |
T 2 WI endometrial stromal sarcoma ( n = 20) | |||
Mean | 0.987 | P < 0.001 | 0.968–0.995 |
Variance | 0.970 | P < 0.001 | 0.927–0.988 |
Skewness | 0.967 | P < 0.001 | 0.918–0.987 |
Kurtosis | 0.963 | P < 0.001 | 0.908–0.985 |
1th percentile | 0.983 | P < 0.001 | 0.957–0.993 |
10th percentile | 0.985 | P < 0.001 | 0.961–0.994 |
50th percentile | 0.985 | P < 0.001 | 0.964–0.994 |
90th percentile | 0.989 | P < 0.001 | 0.973–0.996 |
99th percentile | 0.978 | P < 0.001 | 0.946–0.991 |
ADC Endometrial stromal sarcoma ( n = 20) | |||
Mean | 0.984 | P < 0.001 | 0.959–0.994 |
Variance | 0.916 | P < 0.001 | 0.791–0.968 |
Skewness | 0.891 | P < 0.001 | 0.733–0.958 |
Kurtosis | 0.864 | P < 0.001 | 0.673–0.947 |
1th percentile | 0.908 | P < 0.001 | 0.772–0.965 |
10th percentile | 0.959 | P < 0.001 | 0.895–0.985 |
50th percentile | 0.984 | P < 0.001 | 0.958–0.994 |
90th percentile | 0.975 | P < 0.001 | 0.935–0.991 |
99th percentile | 0.871 | P < 0.001 | 0.689–0.950 |
T 1 CE endometrial stromal sarcoma ( n = 20) | |||
Mean | 0.867 | P < 0.001 | 0.680–0.948 |
Variance | 0.848 | P < 0.001 | 0.639–0.940 |
Skewness | 0.901 | P < 0.001 | 0.755–0.962 |
Kurtosis | 0.741 | P < 0.001 | 0.431–0.895 |
1th percentile | 0.871 | P < 0.001 | 0.690–0.950 |
10th percentile | 0.891 | P < 0.001 | 0.732–0.958 |
50th percentile | 0.899 | P < 0.001 | 0.750–0.961 |
90th percentile | 0.808 | P < 0.001 | 0.558–0.924 |
99th percentile | 0.827 | P < 0.001 | 0.596–0.932 |